Back
 AJAC  Vol.3 No.9 , September 2012
Simultaneous Determination of Amlodipine with H1-Receptor Antagonists by Reversed Phase High Performance Liquid Chromatography and Application to Interaction Studies
Abstract: A rapid, fast and precise method has been developed and validated for the simultaneous determination of amlodipine with H1-receptor antagonists (cetirizine, fexofenadine, and buclizine) from dosage forms. The chromatography was performed on a Purospher? Star, C18 (5 mm, 250 × 4.6 mm) column using acetonitrile: buffer (0.01 mM) (40:60, v/v, pH adjusted to 3.0), as a mobile phase. The mobile phase was pumped at a flow rate of 1.0 mL·min-1 and UV detection was performed at 240 nm. The method was validated for linearity, accuracy, precision and specificity. The method was applied to study the interaction between amlodipine and H1-receptor antagonists. These interactions were carried out in simulated gastric juice (pH 1), simulated full stomach (pH 4), blood pH (pH 7.4) and simulating GI (pH 9). The interacting drugs were heated at 37℃ with intermit-tent shaking and the samples were withdrawn every thirty minutes for three hours and drug contents were analyzed by RP-HPLC techniques. In most cases the in vitro availability of amlodipine was decreased. It was observed that the change in in vitro availability was pH dependent.
Cite this paper: M. Arayne, N. Sultana, S. Bahadur and M. Nawaz, "Simultaneous Determination of Amlodipine with H1-Receptor Antagonists by Reversed Phase High Performance Liquid Chromatography and Application to Interaction Studies," American Journal of Analytical Chemistry, Vol. 3 No. 9, 2012, pp. 632-637. doi: 10.4236/ajac.2012.39082.
References

[1]   R. A. Burges and M. G. Dodd, “Amlodipine,” Cardio-vascular Drug Reviews, Vol. 8, No. 1, 1990, pp. 25-44. doi:10.1111/j.1527-3466.1990.tb00427.x

[2]   R. A. Burges, M. G. Dodd and D. G. Gardiner, “Pharmacologic Profile of Amlodipine,” American Journal of Cardiology, Vol. 64, No. 17, 1989, pp. 101-201. doi:10.1016/0002-9149(89)90956-9

[3]   K. Basavaiah, U. Chandrashekar, H. C. Prameela and P. Nagegowda, “Spectro-photometric and High Performance Liquid Chromatographic Determination of Amlodipine Besylate in Pharmaceuticals,” Science Asia, Vol. 31, No. 1, 2005, pp. 13-21. doi:10.2306/scienceasia1513-1874.2005.31.013

[4]   K. Kamat and S. C. Chaturved, “Stability Indicating Assay Method for Amlodipine Tablets,” Indian Journal of Pharmaceutical Sciences, Vol. 67, No. 2, 2005, pp. 236- 239.

[5]   K. Shimooka, Y. Sawada and H. Tatematsu, “Analysis of Amlodipine in Serum by a Sensitive High Performance Liquid Chromatographic Method with Amperometric Detection,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 7, No. 11, 1989, pp. 1267-1272. doi:10.1016/0731-7085(89)80130-X

[6]   P. K. F. Yeung, S. J. Mosher and P. T. Pollak, “Liquid Chromatography Assay for Amlodipine: Chemical Stability and Pharmacokinetics in Rabbits,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 9, No. 7, 1991, pp. 565-571. doi:10.1016/0731-7085(91)80178-C

[7]   M. Josefsson and B. Norlander, “Coupled-Column Chromatography on a Chiral-AGP Phase for Determination of Amlodipine Enantiomers in Human Plasma: An HPLC Assay with Electrochemical Detection,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 15, No. 2, 1996, pp. 267-277. doi:10.1016/0731-7085(96)01836-5

[8]   S. Tatar and S. Atmaca, “Determination of Amlodipine in Human Plasma by High-Performance Liquid Chromatography with Fluorescence Detection,” Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 758, No. 2, 2001, pp. 305-310. doi:10.1016/S0378-4347(01)00197-9

[9]   G. Bahrami and S. Mirzaeei, “Simple and Rapid HPLC Method for Determination of amlodipine in Human Serum with Fluorescence Detection and Its Use in Pharmacokinetic Studies,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 36, No. 1, 2004, pp. 163-168. doi:10.1016/j.jpba.2004.05.016

[10]   M. Josefsson, A. Zackrisson and B. Norlander, “Sensitive High-Performance Liquid Chromatographic Analysis of Amlodipine in Human Plasma with Amperometric Detection and a Single-Step Solid-Phase Sample Preparation,” Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 672, No. 2, 1995, pp. 310-313. doi:10.1016/0378-4347(95)00231-7

[11]   A. Zarghi, S. M. Foroutan, A. Shafaati and A. Khoddam, “Validated HPLC Method for Determination of Amlodipine in Human Plasma and Its Application to Pharmacokinetic Studies,” II Farmaco, Vol. 60, No. 9, 2005, pp. 789-792. doi:10.1016/j.farmac.2005.06.012

[12]   S. Aryal and N. Skalko-Basnet, “Stability of Amlodipine Besylate and Atenolol in Multi-Component Tablets of Mono-Layer and Bi-Layer Types,” Acta Pharmaceutica, Vol. 58, No. 3, 2008, pp. 299-308. doi:10.2478/v10007-008-0012-5

[13]   C. B. Ganeshbhai, N. M. Patel and P. B. Shah, “Stability Indicating RP-HPLC Method for Simultaneous Determination of Atorvastatin and Amlodipine from Their Combination Drug Products,” Chemical and Pharmaceutical Bulletin, Vol. 55, No. 2, 2007, pp. 241-246. doi:10.1248/cpb.55.241

[14]   R. K. Rajeshwari, G. G. Sankar, A. L. Rao and J. V. L. N. Seshagirirrao, “RP-HPLC Method for the Simultaneous Determination of Atorvastatin and Amlodipine in Tablet Dosage Form,” Indian Journal of Pharmaceutical Sciences, Vol. 68, No. 2, 2006, pp. 275-277. doi:10.4103/0250-474X.25738

[15]   K. R. Naidu, U. N. Kale and M. S. Shingare, “Stability Indicating RP-HPLC Method for Simultaneous Determination of Amlodipine and Benazepril Hydrochloride from Their Combination Drug Product,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 39, No. 1-2, 2004, pp. 147-55. doi:10.1016/j.jpba.2005.04.001

[16]   C. Chen, E. Hanson, J. W. Watson and J. S. Lee, “P-Glycoprotein Limits the Brain Penetration of Nonsedating but Not Sedating H1-Antagonists,” Drug Metabolism and Disposition, Vol. 31, No. 3, 2003, pp. 312-318. doi:10.1124/dmd.31.3.312

[17]   W. T. Stauber, S. H. Ong and R. S. McCuskey, “Selective Extravascular Escape of Albumin into the Cerebral Cortex of the Diabetic Rat,” Diabetes, Vol. 30, No. 6, 1981, pp. 500-503. doi:10.2337/diabetes.30.6.500

[18]   S. Karakus, I. Kucukgüzel and S. G. Kucukgüzel, “Development and Validation of a Rapid RP-HPLC Method for the Determination of Cetirizine or Fexofenadine with Pseudoephedrine in Binary Pharmaceutical Dosage Forms,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 46, No. 2, 2008, pp. 295-302. doi:10.1016/j.jpba.2007.10.018

[19]   A. M. Y. Jaber, H. A. Al Sherife, M. M. Al Omari and A. A. Badwan, “Determination of Cetirizine Dihydrochloride, Related Impurities and Preservatives in Oral Solution and Tablet Dosage Forms Using HPLC,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 36, No. 2, 2004, pp. 341-50. doi:10.1016/j.jpba.2004.07.002

[20]   M. S. Arayne, N. Sultana and M. Nawaz, “Simultaneous Quantitation of Cefpirome and Cetirizine or Levocetirizine in Pharmaceutical Formulations and Human Plasma by RP-HPLC,” Journal of Analytical Chemistry, Vol. 63, No. 9, 2008, pp. 881-887. doi:10.1134/S1061934808090153

[21]   M. S. Arayne, N. Sultana and F. A. Siddiqui, “Simultaneous Determination of Pyri-doxine, Meclizine and Buclizine in Dosage Formulations and Human Serum by RP-LC,” Chromatographia, Vol. 67, No. 11-12, 2008, pp. 941-945. doi:10.1365/s10337-008-0615-5

 
 
Top